We are live on
!
Find out more
PC
PointState Capital Portfolio holdings
AUM
$7.82B
1-Year Est. Return
43.51%
This Fund
S&P 500
This Quarter
Est. Return
+15.51%
1 Year Est. Return
+43.51%
3 Year Est. Return
+157.95%
5 Year Est. Return
+295.76%
10 Year Est. Return
+2,156.01%
AUM
$9.69B
AUM Growth
+$4.83B
(+100%)
Cap. Flow
+$2.02B
Cap. Flow
% of AUM
20.88%
Top 10 Holdings %
Top 10 Hldgs %
49.52%
Holding
195
New
84
Increased
29
Reduced
26
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$323M |
| 2 |
Bausch Health
BHC
|
+$220M |
| 3 |
Humana
HUM
|
+$172M |
| 4 |
Merck
MRK
|
+$170M |
| 5 |
Adobe
ADBE
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$309M |
| 2 |
AGN
Allergan plc
AGN
|
+$163M |
| 3 |
CELG
Celgene Corp
CELG
|
+$124M |
| 4 |
CPN
Calpine Corporation
CPN
|
+$90.8M |
| 5 |
EGN
Energen
EGN
|
+$77.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.02% |
| 2 | Healthcare | 16.74% |
| 3 | Energy | 12.21% |
| 4 | Technology | 10.56% |
| 5 | Financials | 7.85% |
Similar funds
MNA
BFG
PFA
FFM
EMPI
LAM
UB
IMCOOI
PointState Capital's Q3 2016 Portfolio in Review
As of Q3 2016, PointState Capital held 195 positions worth $9.69B, up 100% from $4.85B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
PointState Capital deployed $2.02B of net new capital in Q3 2016, opening 84 new positions and adding to 29 existing holdings. Its largest new stake was Bank of America: 21,685,385 shares worth $339M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 9.5% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $309M trimmed.
- PointState Capital's largest Q3 2016 buy was Bank of America: 21,685,385 shares worth $339M.
- PointState Capital added most to Adobe in Q3 2016, an estimated $146M increase.
- PointState Capital's biggest Q3 2016 reduction was Teva Pharmaceuticals, cutting an estimated $309M.
- PointState Capital fully exited Allergan plc in Q3 2016, selling an estimated $163M.
- PointState Capital's ten largest holdings make up 50% of its $9.69B portfolio in Q3 2016.
- PointState Capital opened 84 new positions and closed 42 in Q3 2016.
- PointState Capital's portfolio value rose 100% quarter-over-quarter to $9.69B.
Based on PointState Capital's 13F filing for Q3 2016, filed 14 Nov 2016.